Surface plasmon resonance technique is particularly interesting in immunology because it has the potential to visualize label-free antigen-antibody interactions in real-time, thus enabling antibody detection and monitoring. Herein we release the guidelines for the correct use of a method to detect specific antibodies directly in Multiple Sclerosis patients’ sera using a glucopeptide-based label-free biosensor. The protocol describes the strategy employed for the immobilization of glucopeptide antigen onto a gold sensor chip and the evaluation of the specific binding of serum antibodies to the immobilized antigen. - Label-free method for the real time screening of disease-specific antibodies within a few minutes; - The described protocol employs small quantities of glucopeptide antigen and blood serum samples saving method-cost; - Stability of the immobilized glucopeptide antigen guarantees the regeneration of the surface allowing re-use the immunosensor with high automated throughput. The antibodies detected using the described methodology can be evaluated as biomarkers of Multiple Sclerosis. The SPR detection system is able to characterize antibodies significantly different from those evaluated in the classical enzyme-linked immunosorbent assays (ELISA).

Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis / Feliciana Real-Fernández; Giada Rossi; Francesco Lolli; Anna Maria Papini; Paolo Rovero. - In: METHODSX (AMSTERDAM). - ISSN 2215-0161. - ELETTRONICO. - 2:(2015), pp. 141-144. [10.1016/j.mex.2015.03.004]

Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis

REAL FERNANDEZ, FELICIANA;ROSSI, GIADA;LOLLI, FRANCESCO;PAPINI, ANNA MARIA;ROVERO, PAOLO
2015

Abstract

Surface plasmon resonance technique is particularly interesting in immunology because it has the potential to visualize label-free antigen-antibody interactions in real-time, thus enabling antibody detection and monitoring. Herein we release the guidelines for the correct use of a method to detect specific antibodies directly in Multiple Sclerosis patients’ sera using a glucopeptide-based label-free biosensor. The protocol describes the strategy employed for the immobilization of glucopeptide antigen onto a gold sensor chip and the evaluation of the specific binding of serum antibodies to the immobilized antigen. - Label-free method for the real time screening of disease-specific antibodies within a few minutes; - The described protocol employs small quantities of glucopeptide antigen and blood serum samples saving method-cost; - Stability of the immobilized glucopeptide antigen guarantees the regeneration of the surface allowing re-use the immunosensor with high automated throughput. The antibodies detected using the described methodology can be evaluated as biomarkers of Multiple Sclerosis. The SPR detection system is able to characterize antibodies significantly different from those evaluated in the classical enzyme-linked immunosorbent assays (ELISA).
2015
2
141
144
Feliciana Real-Fernández; Giada Rossi; Francesco Lolli; Anna Maria Papini; Paolo Rovero
File in questo prodotto:
File Dimensione Formato  
Real-Fernandez-MethodsX-2015.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Creative commons
Dimensione 307.4 kB
Formato Adobe PDF
307.4 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/986611
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
social impact